Candel Therapeutics (CADL) Enterprise Value Growth (1y) (2021 - 2025)
Candel Therapeutics (CADL) Enterprise Value Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Candel Therapeutics | 504.70 Mn | 504.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.64% |
| Sep 30, 2025 | -425.20% |
| Jun 30, 2025 | -369.32% |
| Mar 31, 2025 | -258.44% |
| Dec 31, 2024 | -189.88% |
| Sep 30, 2024 | 61.49% |
| Jun 30, 2024 | 58.66% |
| Mar 31, 2024 | 56.61% |
| Dec 31, 2023 | 49.45% |
| Sep 30, 2023 | 44.29% |
| Jun 30, 2023 | 40.19% |
| Mar 31, 2023 | 37.17% |
| Dec 31, 2022 | 15.23% |
| Sep 30, 2022 | 12.67% |
| Jun 30, 2022 | -256.89% |
| Dec 31, 2021 | -135.76% |